Visus Therapeutics
Biotechnology, Therapeutics
Founded in 1/1/19
Seattle, Washington, United States
For Profit
About Visus Therapeutics
Visus Therapeutics is a clinical-stage company developing innovative medicines to improve the vision for people around the world.
Company Metrics
- Employees: 11-50
- Monthly Visits: 2184
- Tech Stack: None active products
Financial Information
- Estimated Revenue: Less than $1M
- Total Funding: 56000000 USD
- Last Funding: 20000000 USD (Debt Financing)
- Funding Status: Early Stage Venture
Technology Stack
Visus Therapeutics actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology, Therapeutics
Headquarters: Seattle, Washington, United States
Employees
- Ben Bergo - Chief Executive Officer (LinkedIn)
- David Toll - Chief Financial Officer (LinkedIn)
- Rhett Mhsa - Chief Medical Officer and Head of R&D (LinkedIn)
- Tim Grinstead - Chief Operating Officer (LinkedIn)